Effects of exenatide on coronary stent's endothelialization in subjects with type 2 diabetes: a randomized controlled trial. The Rebuild study.

Santos-Pardo, Irene; Witt, Nils; Angerås, Oskar; Nyström, Thomas

Santos-Pardo, Irene; Witt, Nils; Angerås, Oskar; Nyström, Thomas.

Affiliation

Santos-Pardo I; Department of Clinical Science and Education, Karolinska Institute, Unit of Cardiology, Södersjukhuset, Stockholm, Sweden. irene.santos-pardo@regionstockholm.se.
Witt N; Department of Cardiology, Södersjukhuset. Sjukhusbacken 10, 11883, Stockholm, Sweden. irene.santos-pardo@regionstockholm.se.
Angerås O; Department of Clinical Science and Education, Karolinska Institute, Unit of Cardiology, Södersjukhuset, Stockholm, Sweden.
Nyström T; Department of Cardiology, Södersjukhuset. Sjukhusbacken 10, 11883, Stockholm, Sweden.

Cardiovasc Diabetol ; 22(1): 337, 2023 12 08.

Article in En | MEDLINE | ID: mdl-38066597

Subject(s)

Diabetes Mellitus, Type 2; Exenatide; Percutaneous Coronary Intervention; Humans; Atherosclerosis/pathology; Coronary Angiography; Coronary Restenosis/diagnostic imaging; Coronary Restenosis/etiology; Coronary Restenosis/pathology; Coronary Vessels/pathology; Diabetes Mellitus, Type 2/diagnosis; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/pathology; Drug-Eluting Stents; Exenatide/therapeutic use; Stents; Tomography, Optical Coherence/methods; Treatment Outcome

Key words

Drug eluting stent; Exenatide; Glucagon-like peptide-1 receptor agonists; Stent endothelialization; Type 2 diabetes

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Percutaneous Coronary Intervention / Exenatide Limits: Humans Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2023 Type: Article Affiliation country: Sweden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google